IL-2 antagonists: the European perspective (Q40419248)

20 September 2017

IL-2 antagonists: the European perspective (English)

1 reference

20 September 2017

Platz KP

1

1 reference

20 September 2017

Braun F

2

1 reference

20 September 2017

Fändrich F

3

1 reference

20 September 2017

Kremer B

4

1 reference

20 September 2017

Mueller AR

5

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

Transplantation Proceedings

20 September 2017

1 reference

20 September 2017

37

1 reference

20 September 2017

4

1 reference

20 September 2017

1783-1784

1 reference

Basiliximab decreases the incidence of acute rejection after intestinal transplantation

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.03.131

Immunosuppression following intestinal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.03.131

Intestinal transplantation before and after the introduction of sirolimus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.03.131

Induction therapy with daclizumab as part of the immunosuppressive regimen in human small bowel and multiorgan transplants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.03.131

Tacrolimus, daclizumab, sirolimus, and budesonide after small bowel transplantation in order to reduce nephrotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.03.131

10.1016/J.TRANSPROCEED.2005.03.131

7 January 2021

Identifiers

DOI

1 reference

release_xaigksqycnbd5ncl35hccjssr4

20 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xaigksqycnbd5ncl35hccjssr4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference